Showing results (81-90 of 164) with videos related to
Sort By:
Pageof 17
Gene|February 21, 2025
RNA research for drug discovery: Recent advances and critical insightPatrick Maduabuchi Aja, Peter Chinedu Agu, Celestine Ogbu, et al.The Journal of Allergy and Clinical Immunology|May 9, 2017
Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczemaMartina S Elias, Heather A Long, Carla F Newman, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort studyLeila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas, et al.The Journal of Allergy and Clinical Immunology|March 4, 2008
Filaggrin null mutations and childhood atopic eczema: a population-based case-control studySara J Brown, Caroline L Relton, Haihui Liao, et al.Trials|February 12, 2020
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trialSuzie Cro, Prakash Patel, Jonathan Barker, et al.The Journal of Investigative Dermatology|October 22, 2017
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Zenas Z N Yiu, Catherine H Smith, Darren M Ashcroft, et al.The Plant Journal : for Cell and Molecular Biology|May 14, 2013
PpeTAC1 promotes the horizontal growth of branches in peach trees and is a member of a functionally conserved gene family found in diverse plants speciesChris Dardick, Ann Callahan, Renate Horn, et al.The Journal of Investigative Dermatology|October 30, 2017
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Ireny Y K Iskandar, Richard B Warren, Mark Lunt, et al.Clinical and Experimental Dermatology|May 22, 2025
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohortOras A Alabas, Ian Evans, Kathleen Mcelhone, et al.Plos Medicine|October 27, 2023
Ethnic differences in early onset multimorbidity and associations with health service use, long-term prescribing, years of life lost, and mortality: A cross-sectional study using clustering in the UK Clinical Practice Research DatalinkFabiola Eto, Miriam Samuel, Rafael Henkin, et al.Pageof 17